Lehtonen J Y, Rytömaa M, Kinnunen P K
Department of Medical Chemistry, Institute of Biomedicine, University of Helsinki, Finland.
Biophys J. 1996 May;70(5):2185-2194. doi: 10.1016/S0006-3495(96)79784-9.
Tacrine (1,2,3,4-tetrahydro-9-acridinamine monohydrate) is an inhibitor of acetylcholinesterase currently used in the treatment of the symptoms of Alzheimer's disease. The present study demonstrates preferential binding of this drug to acidic phospholipids, as revealed by fluorescence polarization, penetration into lipid monolayers, and effects on the thermal phase behavior of dimyristoyl phosphatidic acid (DMPA). A fivefold enhancement in the polarization of tacrine emission is evident above the main phase transition temperature (T(m)) of DMPA vesicles, whereas below T(m) only a 0.75-fold increase is observed. In contrast, the binding of tacrine to another acidic phospholipid, dimyristoylphosphatidylglycerol, did not exhibit strong dependence on T(m). In accordance with the electrostatic nature of the membrane association of tacrine, the extent of binding was augmented with increasing contents of egg PG in phosphatidylcholine liposomes. Furthermore, [NaCl] > 50 mM dissociates tacrine (albeit incompletely) from the liposomes composed of acidic phospholipids. Inclusion of the cationic amphiphile sphingosine in egg PG vesicles decreased the membrane association of tacrine until at 1:1 sphingosine: egg PG stoichiometry binding was no longer evident. Tacrine also penetrated into egg PG but not into egg PC monolayers. Together with broadening of the main transition and causing a shoulder on its high temperature side, the binding of tacrine to DMPA liposomes results in a concentration-dependent reduction both in the combined enthalpy delta H of the above overlapping endotherms and the main transition temperature T(m). Interestingly, these changes in the thermal phase behavior of DMPA as a function of the content of the drug in vesicles were strongly nonlinear. More specifically, upon increasing [tacrine], T(m) exhibited stepwise decrements. Simultaneously, sharp minima in delta H were observed at drug:lipid stoichiometries of approximately 2:100 and 25:100, whereas a sharp maximum in delta H was evident at 18:100. The above results are in keeping with tacrine causing phase separation processes in the bilayer and may also relate to microscopic drug-induced ordering processes within the membrane.
他克林(1,2,3,4-四氢-9-吖啶胺一水合物)是一种乙酰胆碱酯酶抑制剂,目前用于治疗阿尔茨海默病的症状。本研究表明,通过荧光偏振、脂质单层渗透以及对二肉豆蔻酰磷脂酸(DMPA)热相行为的影响揭示,该药物优先与酸性磷脂结合。在DMPA囊泡的主相变温度(T(m))以上,他克林发射的偏振增强了五倍,而在T(m)以下,仅观察到0.75倍的增加。相比之下,他克林与另一种酸性磷脂二肉豆蔻酰磷脂酰甘油的结合对T(m)没有强烈依赖性。根据他克林膜结合的静电性质,随着磷脂酰胆碱脂质体中鸡蛋PG含量的增加,结合程度增强。此外,[NaCl]>50 mM时,他克林(尽管不完全)从由酸性磷脂组成的脂质体中解离。在鸡蛋PG囊泡中加入阳离子两亲物鞘氨醇会降低他克林的膜结合,直到鞘氨醇:鸡蛋PG化学计量比为1:1时,结合不再明显。他克林也能渗透到鸡蛋PG中,但不能渗透到鸡蛋PC单层中。除了使主转变变宽并在其高温侧产生一个肩峰外,他克林与DMPA脂质体的结合还导致上述重叠吸热峰的组合焓δH和主转变温度T(m)均呈浓度依赖性降低。有趣的是,DMPA热相行为随囊泡中药物含量的这些变化呈强烈的非线性。更具体地说,随着[他克林]的增加,T(m)呈现逐步下降。同时,在药物:脂质化学计量比约为2:100和25:100时,观察到δH出现急剧最小值,而在18:100时,δH出现急剧最大值。上述结果与他克林在双层膜中引起相分离过程一致,也可能与膜内微观药物诱导的有序过程有关。